Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Market Closed 04-24 16:00:00 EDT

22.48

-0.78

-3.35%

盘后22.47

-0.01-0.04%

19:59 EDT

High23.44	Low21.71	Vol2.62M
Open23.26	D1 Closing23.26	Amplitude7.45%
Mkt Cap2.24B	Tradable Cap2.11B	Total Shares99.70M
T/O58.90M	T/O Rate2.80%	Tradable Shares93.74M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":22.48,"timestamp":1777060800000,"preClose":23.26,"halted":0,"volume":2621503,"hourTrading":{"tag":"盘后","latestPrice":22.47,"preClose":22.48,"latestTime":"19:59 EDT","volume":64252,"amount":1444665.1398,"timestamp":1777075163024,"change":-0.01,"changeRate":-0.000445,"amplitude":0.005356},"delay":0,"changeRate":-0.03353396388650048,"floatShares":93736700,"shares":99698129,"eps":-2.059999,"marketStatus":"Market Closed","change":-0.78,"latestTime":"04-24 16:00:00 EDT","open":23.26,"high":23.44,"low":21.706,"amount":58901423.66071,"amplitude":0.074549,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.059999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":23.26,"preHourTrading":{"tag":"盘前","latestPrice":23.29,"preClose":23.26,"latestTime":"09:29 EDT","volume":14645,"amount":342204.779635,"timestamp":1777037399999,"change":0.03,"changeRate":0.00129,"amplitude":0.0546},"postHourTrading":{"tag":"盘后","latestPrice":22.47,"preClose":22.48,"latestTime":"19:59 EDT","volume":64252,"amount":1444665.1398,"timestamp":1777075163024,"change":-0.01,"changeRate":-0.000445,"amplitude":0.005356},"volumeRatio":0.9025987399364624,"impliedVol":1.0063,"impliedVolPercentile":0.9412},"requestUrl":"/m/hq/s/DFTX/tweets","defaultTab":"tweets","newsList":[{"id":"2630827395","title":"Definium Therapeutics (DFTX): Late-Stage DT120 Psychedelic Pipeline and Multiple Near-Term Catalysts Support Buy Rating and $61 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2630827395","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630827395?lang=en_us&edition=fundamental","pubTime":"2026-04-25 03:45","pubTimestamp":1777059925,"startTime":"0","endTime":"0","summary":"Analyst Justin Walsh from JonesTrading reiterated a Buy rating on Definium Therapeutics and keeping the price target at $61.00. Justin Walsh has gi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-dftx-late-stage-dt120-psychedelic-pipeline-and-multiple-near-term-catalysts-support-buy-rating-and-61-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-dftx-late-stage-dt120-psychedelic-pipeline-and-multiple-near-term-catalysts-support-buy-rating-and-61-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","SSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630825711","title":"Psychedelic Pharma Stocks Are Riding High. Past Cannabis Returns Are a Reality Check. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2630825711","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630825711?lang=en_us&edition=fundamental","pubTime":"2026-04-24 23:58","pubTimestamp":1777046280,"startTime":"0","endTime":"0","summary":"I've never gone on one of those self-discovery trips where an Amazonian shaman administers hallucinogenic brew made from the ayahuasca vine. But I did overshare here recently about my Atomic Fireball habit, and while they're usually individually wrapped, I found a packet with two the other day, so I doubled up. During the deep introspection that followed, a spirit guide whispered into my ear: Are psychedelic stocks overpriced?I didn't answer; I have a hard enough time figuring out momentum stocks in this dimension. But he might have been on to something.This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSOX","MJ","DFTX","CMPS","BK4139","BK4007","BK4539","TOKE","CNBS","MSOS","ATAI","WEED","YOLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842685","title":"Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842685?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037539,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nL4N4171CD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","CMPS","BK4139","BK4007","BK4539","GHRS","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842681","title":"Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842681?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037538,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nL4N4171CD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ENVB","GHRS","BK4539","DFTX","BK4139","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629426838","title":"Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2629426838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629426838?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037537,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nL4N4171CD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","CMPS","BK4139","BK4007","BK4539","GHRS","ENVB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629830008","title":"Oppenheimer Adjusts Definium Therapeutics PT to $40 From $25, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830008","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629830008?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:02","pubTimestamp":1776952941,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of Buy and mean price target of $38.87, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629832855","title":"Definium Therapeutics price target raised to $40 from $25 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629832855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629832855?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:59","pubTimestamp":1776949189,"startTime":"0","endTime":"0","summary":"Oppenheimer raised the firm’s price target on Definium Therapeutics (DFTX) to $40 from $25 and keeps an Outperform rating on the shares. The firm a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-40-from-25-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-40-from-25-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629831820","title":"Definium Therapeutics : Oppenheimer Raises Target Price to $40 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2629831820","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629831820?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:23","pubTimestamp":1776946992,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nAZN4SSCNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835592","title":"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Zymeworks (ZYME) and Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835592?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:21","pubTimestamp":1776943291,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sanofi (SNYNF), Zymeworks (ZYME) and Definium Therap...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-zymeworks-zyme-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-zymeworks-zyme-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","ZYME","BK4585","HCSG","BK4007","LU0128526141.USD","BK4137","LU0029874061.USD","BK4139","SNYNF","XLV","BK4588","DFTX","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835596","title":"Piper Sandler Sticks to Its Buy Rating for Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835596?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:20","pubTimestamp":1776943241,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Amsellem reiterated a Buy rating on Definium Therapeutics today and set a price target of $49.00. Amsellem covers the H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629831298","title":"U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=2629831298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629831298?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:46","pubTimestamp":1776930366,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas InstrumentsApril 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL4N4160NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAN","CPNG","DLR","AMZY","CLX","CSX","COTY","ELV","AMZD","EFOR","EWBC","LNG","OZK","ABBV","GEV","BKU","CME","DTM","AMZZ","BWA","T","GEVX","CBRE","CYH","AMZN","GEVG","AKAM","CAR","CPAY","MMM","CHEF","CSGP","CRGY","AMZP","DFTX","CHTR","AMZU","CL","CCS","TXN","CALX","AZYY","BIIB","COF","ASTI","CPT","BSX","BA","ASGN","AVB","ELF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629553076","title":"Definium Therapeutics: Strengthened Investment Case and Multi-Indication Upside Ahead of Key Phase 3 Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2629553076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629553076?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:55","pubTimestamp":1776894925,"startTime":"0","endTime":"0","summary":"Needham analyst Ami Fadia maintained a Buy rating on Definium Therapeutics today and set a price target of $28.00. Ami Fadia has given his Buy rati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-strengthened-investment-case-and-multi-indication-upside-ahead-of-key-phase-3-readouts-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-strengthened-investment-case-and-multi-indication-upside-ahead-of-key-phase-3-readouts-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629207810","title":"Definium plans Phase 3 Haven trial of DT120 ODT in PTSD for 2027 start","url":"https://stock-news.laohu8.com/highlight/detail?id=2629207810","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629207810?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:36","pubTimestamp":1776890211,"startTime":"0","endTime":"0","summary":"Definium outlined near-term catalysts for DT120 ODT, with pivotal topline results scheduled for late 2Q 2026 through late 3Q 2026, meaning no new results were presented.MDD program remains central to value creation, with Emerge topline data expected late 2Q 2026.GAD readouts remain on track, with Voyage expected early 3Q 2026; Panorama timing shifted to late 3Q 2026 following a blinded reassessment of enrollment needs.Pipeline scope expanded into PTSD, with Phase 3 Haven initiation planned for 2027.Company positioned DT120 ODT as a scalable commercial franchise, targeting broad adoption across care settings ahead of potential regulatory filings.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL1JM1Tg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629078346","title":"Definium Therapeutics publishes Investor and Analyst Day presentation materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629078346?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:27","pubTimestamp":1776889671,"startTime":"0","endTime":"0","summary":"Definium published Investor and Analyst Day presentation outlining DT120 ODT  clinical program milestones in MDD, GAD, PTSD.Emerge Phase 3 in MDD fully enrolled with 149 participants; topline data expected late 2Q 2026.PTSD expansion includes planned Phase 3 Haven study with about 200 participants; initiation expected in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on April 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL9HvyzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629702641","title":"Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX) and Certara (CERT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629702641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629702641?lang=en_us&edition=fundamental","pubTime":"2026-04-23 00:40","pubTimestamp":1776876008,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definium Therapeutics (DFTX) and Certara (CERT). Definium Therape...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CERT","LU0029874061.USD","DFTX","XBI","HCSG","BK4137","XLV","BK4588","LABU","BK4585","BK4007","LU0128526141.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629047156","title":"Definium Therapeutics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2629047156","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629047156?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:06","pubTimestamp":1776866760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2026 10:06 ET (14:06 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010308","title":"Definium Therapeutics Inc : Leerink Partners Raises Target Price to $30  From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010308?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:53","pubTimestamp":1776855219,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172482246","title":"Stock Track | Definium Therapeutics Soars 6.34% in Pre-market on Trump Executive Order Boosting Psychedelic Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1172482246","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172482246?lang=en_us&edition=fundamental","pubTime":"2026-04-21 17:11","pubTimestamp":1776762674,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' stock surged 6.34% in pre-market trading on Tuesday, continuing the strong momentum in psychedelic-focused biotech stocks.The rally was triggered by President Donald Trump's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b19553a137a2d518dfc18efdd547e678","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629086910","title":"Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2629086910","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629086910?lang=en_us&edition=fundamental","pubTime":"2026-04-21 15:44","pubTimestamp":1776757440,"startTime":"0","endTime":"0","summary":"Definium Therapeutics stock rises after hours amid psychedelic sector rally following Trump's regulatory push.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/21/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/21/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/04/51930842/definium-therapeutics-dftx-stock-gains-after-hours-heres-whats-driving-the-move","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51930842/definium-therapeutics-dftx-stock-gains-after-hours-heres-whats-driving-the-move","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168677170","title":"Stock Track | Definium Therapeutics Soars 5.65% as Trump Executive Order Boosts Psychedelic Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1168677170","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168677170?lang=en_us&edition=fundamental","pubTime":"2026-04-21 10:07","pubTimestamp":1776737240,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' stock surged 5.65% during Monday's trading session, mirroring gains across the psychedelic drug development sector following a significant regulatory announcement from the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b19553a137a2d518dfc18efdd547e678","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":0.2171},{"period":"3month","weight":0.292},{"period":"6month","weight":0.8158},{"period":"1year","weight":2.4961},{"period":"ytd","weight":0.6789}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.044052},{"month":5,"riseRate":0.4,"avgChangeRate":-0.002468},{"month":6,"riseRate":0.4,"avgChangeRate":-0.111207},{"month":7,"riseRate":0.8,"avgChangeRate":0.20763},{"month":8,"riseRate":0.2,"avgChangeRate":-0.091548},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}